You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SGLT2

Showing 1 - 25 of 731
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Kidney Injury Trial (SGLT2 inhibitor)

Not yet recruiting
  • Acute Kidney Injury
  • SGLT2 inhibitor
  • (no location specified)
Nov 3, 2023

Transplant; Failure, Heart, Cardiac Allograft Vasculopathy, Rejection Heart Transplant Trial (SGLT2i)

Not yet recruiting
  • Transplant; Failure, Heart
  • +2 more
  • (no location specified)
Nov 19, 2023

SGLT2 Inhibition in Heart Failure

Recruiting
  • Heart Failure
  • Sodium-glucose cotransporter 2 inhibitor
  • Belfast, United Kingdom
    Belfast Health and Social Care Trust
Nov 15, 2023

Heart Failure Acute, Ventilator Lung Trial in Taipei (SGLT2 inhibitor)

Recruiting
  • Heart Failure Acute
  • Ventilator Lung
  • SGLT2 inhibitor
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 16, 2023

Polycystic Ovary Syndrome Trial (SGLT2 inhibitors combined with metformin, Placebo combined with metformin)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • SGLT2 inhibitors combined with metformin
  • Placebo combined with metformin
  • (no location specified)
Jul 21, 2023

Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure Trial

Not yet recruiting
  • Heart Failure NYHA Class II
  • +2 more
    • (no location specified)
    May 22, 2023

    Ketoses, Metabolic Trial (SGLT2 inhibitor + low-carb diet, + low-carb diet)

    Not yet recruiting
    • Ketoses, Metabolic
    • SGLT2 inhibitor + low-carb diet
    • placebo + low-carb diet
    • (no location specified)
    Dec 28, 2022

    Cystic Fibrosis-related Diabetes, Cystic Fibrosis Trial in Minneapolis (Empagliflozin, Placebo Control)

    Not yet recruiting
    • Cystic Fibrosis-related Diabetes
    • Cystic Fibrosis
    • Minneapolis, Minnesota
      University of Minnesota
    Nov 20, 2023

    SGLT2 for Heart Failure in CHD Patients

    Not yet recruiting
    • Heart Failure
      • Nice, France
        University hospital of Nice
      Jun 7, 2023

      Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

      Not yet recruiting
      • Fatty Liver, Nonalcoholic
      • SGLT2 inhibitor
      • (no location specified)
      Oct 31, 2023

      SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )

      Active, not recruiting
      • SLE
      • +2 more
      • Mansoura, Egypt
        Urology and Nephrology Center
      Feb 18, 2023

      The Triglyceride/Glucose Index and SGLT-2 Inhibitors

      Recruiting
      • Metabolic Disease
      • Diabetes
      • SGLT-2 inhibitors
      • Samsun, İlkadım, Turkey
        Samsun Education and Research Hospital
      Jun 14, 2023

      (NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
      • (no location specified)
      May 22, 2023

      Type 2 Diabetes Trial (SGLT2 inhibitor)

      Not yet recruiting
      • Type 2 Diabetes Mellitus
      • SGLT2 inhibitor
      • (no location specified)
      Feb 12, 2023

      Chronic Kidney Diseases, Diabetes, PreDiabetes Trial in Vienna (Therapeutic carbohydrate restriction combined with an

      Recruiting
      • Chronic Kidney Diseases
      • +3 more
      • Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor
      • Vienna, Austria
        6th Medical Department with Nephrology and Dialysis, Clinik Otta
      Oct 16, 2023

      SGLT2-I Use in DFUD: a Delphi Study

      Not yet recruiting
      • Diabetic Foot Ulcer
      • eDelphi method
      • (no location specified)
      Aug 14, 2023

      Type 2 Diabetes, Type 1 Diabetes Trial in San Antonio (Empagliflozin 25 MG, Placebo)

      Not yet recruiting
      • Type 2 Diabetes
      • Type 1 Diabetes
      • Empagliflozin 25 MG
      • Placebo
      • San Antonio, Texas
        Texas Diabetes Institute/UH
      Jul 31, 2023

      Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

      Not yet recruiting
      • Lupus Nephritis
      • Chronic Kidney Diseases
      • Dapagliflozin 10mg Tab
      • Standard maintenance therapy
      • Hong Kong, Hong Kong
        Queen Mary Hospital
      Nov 24, 2023

      Obesity, Weight Loss Trial in Birmingham (Empagliflozin Arm, Control Arm, Exercise capacity VO2 maximum determination)

      Not yet recruiting
      • Obesity
      • Weight Loss
      • Empagliflozin Arm
      • +3 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      May 22, 2023

      Obesity, Metabolic Syndrome Trial in Nashville (Empagliflozin 25 MG, Placebo)

      Not yet recruiting
      • Obesity
      • Metabolic Syndrome
      • Empagliflozin 25 MG
      • Placebo
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jul 24, 2023

      Heart Failure, Hypertension, Left Ventricle Remodeling Trial (Empagliflozin 10 MG, Placebo)

      Not yet recruiting
      • Heart Failure
      • +3 more
      • Empagliflozin 10 MG
      • Placebo
      • (no location specified)
      Sep 20, 2023

      Cancers Among Diabetics ,Observational Study

      Enrolling by invitation
      • Cancer
      • +3 more
      • interleukin 6
      • Riyadh, N/A (Non-US), Saudi Arabia
        ministry of health , First health cluster , Riaydh
      Oct 28, 2022

      SGLT2 INHIBITORS, Lupus Nephritis, BMD Trial in Mansoura (Dapagliflozin tablet, )

      Active, not recruiting
      • SGLT2 INHIBITORS
      • +2 more
      • Dapagliflozin tablet
      • placebo
      • Mansoura, Egypt
        Urology and Nephrology Center
      Jan 19, 2023

      SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

      Recruiting
      • Coronary Artery Disease
      • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
      • Shah Alam, Selangor, Malaysia
        Institute for Clinical Research, National Institutes of Health,
      Nov 9, 2023

      Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)

      Not yet recruiting
      • Heart Failure With Preserved Ejection Fraction
      • Diabete Type 2
      • Cairo, Egypt
        clinical research uint- El-sheikh zayed specialized hospital SMC
      Oct 8, 2023